171 results on '"Jenkner, Alessandro"'
Search Results
2. Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection
3. Stimulation of Treg Cells to Inhibit Osteoclastogenesis in Gorham-Stout Disease
4. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
5. Dysregulated miRNAs in bone cells of patients with Gorham‐Stout disease
6. Expression of Glial Cell Line-Derived Neurotrophic Factor and Neurturin in Mature Kidney, Nephrogenic Rests, and Nephroblastoma: Possible Role as Differentiating Factors
7. Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
8. Trimming long-term tunneled central venous catheters in pediatric patients
9. Highlighting the bone cells alterations in Gorham-Stout Disease
10. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
11. Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response
12. Local lymph node involvement in pediatric renal cell carcinoma: A report from the Italian TREP project
13. Treatment of High-Risk Relapsed Wilms Tumor With Dose-Intensive Chemotherapy, Marrow-Ablative Chemotherapy, and Autologous Hematopoietic Stem Cell Support: Experience by the Italian Association of Pediatric Hematology and Oncology
14. O.014 RELATIONSHIP BETWEEN THE WILMS TUMOR AND THE NEOPLASTIC THROMBOSIS: DOES IT INFLUENCE THE OUTCOME?
15. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors: The Bambino Gesù Childrenʼs Hospital experience
16. EFFECTIVENESS OF ICE-CAV IN HIGH RISK EWING SARCOMA FAMILY TUMORS: A PILOT STUDY: P.D.030
17. Renal Cell Carcinoma in Children: A Clinicopathologic Study
18. Spastic diplegia and interferon
19. 111 renal neoplasms of childhood: A clinicopathologic study
20. Additional file 7: of Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
21. Additional file 4: of Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
22. Additional file 9: of Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
23. Additional file 11: of Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
24. Additional file 5: of Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
25. Susceptibility to allergy in adoptive children: a cross-sectional study at “Bambino Gesù Children’s Hospital”
26. Additional file 2: of Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review
27. Additional file 1: of Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review
28. Identification of bone remodelling alterations in Gorham-Stout disease
29. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis
30. Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection
31. Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review
32. Local control in metastatic neuroblastoma in children over 1 year of age
33. Recurrent Metanephric Stromal Tumor in an Infant
34. Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma
35. Microscopic neoplastic thrombosis in localised nephroblastoma: does it influence outcome?
36. Trimming long‐term tunneled central venous catheters in pediatric patients
37. Continuing Response to Subsequent Treatment Lines With Tyrosine Kinase Inhibitors in an Adolescent With Metastatic Renal Cell Carcinoma
38. Microscopic neoplastic thrombosis in localised nephroblastoma: Does it influence outcome?
39. Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma
40. Tyrosinemia Type 1: Metastatic Hepatoblastoma With a Favorable Outcome
41. Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry
42. Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response
43. Prolonged Response to Oral Gefitinib, Cyclophophamide, and Topotecan in Heavily Pretreated Relapsed Stage 4 Neuroblastoma
44. Pulmonary Blastomas of Childhood: Histologic, Immunohistochemical, Ultrastructural Aspects and Therapeutic Considerations
45. Antibiotic Lock With Vancomycin and Urokinase Can Successfully Treat Colonized Central Venous Catheters in Pediatric Cancer Patients
46. NEOPLASTIC DISEASE AND DELETION 22q11.2: A MULTICENTRIC STUDY AND REPORT OF TWO CASES
47. Expression of the Lipogenic Enzyme Fatty Acid Synthase (FAS) in Retinoblastoma and Its Correlation with Tumor Aggressiveness
48. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: An interinstitutional study
49. Nephroblastoma
50. NEPHROBLASTOMA. DNA CHARACTERISTICS AND THEIR MODIFICATIONS INDUCED BY PRENEPHRECTOMY CHEMOTHERAPY: A CYTOFLUORIMETRIC STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.